Acute myeloid m2 is a partially differentiated form of acute granulocytic leukemia, a type of myeloid leukemia. Its pathogenesis may be related to several factors: biological factors, including viral infections and abnormalities in immune function; physical factors, including ionizing radiation such as X-rays and gamma rays, and exposure to very high levels of radiation; chemical factors, which are induced by prolonged exposure to benzene and benzene organic solvents; and genetic factors, as certain inherited disorders, such as Down’s syndrome, may increase the risk of developing the disease. This type of leukemia has an acute onset and a short course, often with anemia, fever, and bleeding as the main manifestations. It is accompanied by obvious signs of infection and organ infiltration with enlargement of lymph nodes and liver and spleen. If the diagnosis of AML m2 is confirmed, it is recommended to go to the hospital in time and under the guidance of the doctor to carry out standardized treatment in order to reduce the adverse effects of the disease.